Emergen Research has recently added a new report titled Global Direct-to-Consumer Genetic Testing Market that provides an extensive analysis of the Direct-to-Consumer Genetic Testing market and industry overview with regards to market size, market share, revenue growth, key companies, current and emerging market trends, recent technological and product developments, and a comprehensive analysis of the impact of COVID-19 pandemic on the growth of the Direct-to-Consumer Genetic Testing market.
The latest research report, titled ‘Global Direct-to-Consumer Genetic Testing Market’, can be considered a profound analysis of the global Direct-to-Consumer Genetic Testing industry that focuses on crucial data and information pertaining to the sales and revenue shares. The market evaluations over the forecast years are based on a comprehensive analysis of the leading market segments, such as product type outlook, application continuum, regional overview, and competitive landscape of the global Direct-to-Consumer Genetic Testing market.
The global Direct-to-Consumer Genetic Testing Market is forecasted to reach USD 3.33 Billion by 2027, according to a new report by Emergen Research. Increasing genetic disease incidence would fuel competition for direct-to-consumer genetic testing and accelerate market development across the expected timeframe. Increasing cases of hereditary disorders such as breast cancer, achondroplasia, colorectal cancer and other diseases have increased the need for cost-effective and reliable avenues of genetic testing in the healthcare industry. For reference, according to the World Cancer Research Fund (WCRF), more than 2 million new cancer cases were reported globally in 2018. Breast cancer is now considered to be the second most prevalent disease. The introduction of a superior standard and innovative direct-to-consumer genetic testing has significantly lowered mortality levels of people with cancer by maintaining diligence surveillance data even before the onset of the disease. The preceding conditions would, therefore, accelerate the demand for direct-to-consumer genetic testing to reverse the timetable for the prediction.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/20
The report bifurcates the Direct-to-Consumer Genetic Testing market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
Key Companies Profiled in the Report:
23andMe, Full Genome Corporation, Color Genomics, Genesis Healthcare, Helix OpCo LLC, FamilyTreeDNA, MyHeritage, Identigene, Pathway genomics, and Living DNA, among others
Key Reasons to Buy This Report:
- The report presents a thorough examination of the Direct-to-Consumer Genetic Testing market, elaborating on its core segments. The report conducts historical and future assessments of the market dynamics and offers precise data in a well-organized order.
- The report evaluates the most prominent market growth potentials, dynamic market trends, driving factors, restraints, investment opportunities, and threats.
- The report is inclusive of an in-depth study of the industry variables, manufacturers’ value chain, sales volume, market share, competitive landscape, and effective business tactics.
- Besides offering a vivid depiction of the global Direct-to-Consumer Genetic Testing business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.
- The strategic marketing recommendations, crucial information related to the new market entrants, and expansion plans of various businesses are poised to provide the reader with a competitive edge in the market.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market
A SWOT analysis is performed on the leading companies engaged in the Direct-to-Consumer Genetic Testing market to offer a better understanding of the strengths, opportunities, weaknesses, and threats of the leading companies. It also covers production and consumption rate, the volatility of prices and demands, market share, market size, global position, and market position of each player.
Direct-to-Consumer Genetic Testing Market Segmentation:
Test Type Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Carrier Testing
- Predictive Testing
- Ancestry & Relationship Testing
- Nutrigenomics Testing
Distribution Channel Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
- Online Platforms
Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Targeted Analysis
- Single Nucleotide Polymorphism Chips (SNP)
- Whole Genome Sequencing (WGS)
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/20
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights